Mike Kiklis leverages his 25 years of experience in providing representation to clients in his areas of focus: patent litigation and trials at the USPTO Patent Trial and Appeal Board (PTAB). He has been involved in approximately 100 PTAB trials, serving as lead counsel in the vast majority of those cases. He also handles appeals to the Federal Circuit from his cases, having now been involved in over 20 appeals. He both enforces and defends the intellectual property rights of his clients, and is often called upon to handle cases worth more than $100 million.
Mike brings an in-depth understanding of the business and IP needs of his technology clients, which he developed from years of experience in virtually every kind of patent matter, from cross-licensing and due diligence to bet-the-company PTAB trials and patent litigation. Mike has an extensive background in computer science based on his prior work as a software developer at some of the computer industry’s leading companies.
Mike works with leaders at technology-based companies to navigate through various degrees of patent disputes. His practice includes:
Mike provides significant and influential thought leadership as a frequent speaker and author on patent law, including patentable subject matter and PTAB trials. He is also the author of The Supreme Court on Patent Law, an 800-page treatise devoted to the Supreme Court’s patent law jurisprudence.
American Bar Association
American Intellectual Property Law Association (AIPLA)
Intellectual Property Owners Association (IPO) – Software Related Inventions Committee
Boston University, The Metropolitan College Dean’s Advisory Board Member
Represented Life Technologies Corp. in a Federal Circuit Appeal stemming from a 2017 Patent Trial and Appeal Board (PTAB) decision in a covered business method proceeding (CBM). Michael Kiklis represented Life Technologies in two covered business method proceedings: one was filed in 2014 and the other was filed in 2015. Life Technologies prevailed in both proceedings with the PTAB finding that all challenged claims of Unisone Strategic IP Inc.’s inventory management patent recited ineligible subject matter pursuant to 35 U.S.C. § 101. This appeal involved the second CBM. Unisone chose not to appeal the first CBM. The Federal Circuit heard oral argument on December 4, 2018, and then affirmed the PTAB’s decision less than one week later.
Intellectual Asset Management (IAM) Patent 1000: The World’s Leading Patent Practitioners — (2014-2019)
IP STARS — Patent Star (2013-2019)
Boston University Metropolitan College Computer Science Distinguished Alumni Award
Patent and Trademark Office Society’s Rossman Award